drugset / Trial / NCT03256487

Intravenous Buprenorphine Versus Morphine for Severe Pain in the Emergency Department

NCT03256487

Phase 2 Unknown 122 enrolled Alameda Health System
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study evaluates intravenous (IV) buprenorphine versus IV morphine for the management of severe, acute pain among emergency department (ED) patients. ED patients with severe pain will be randomized in equal proportion to receive IV buprenorphine or IV morphine.

Timeline

Start
2017-09-26
Primary completion
2018-02-01
Completion
2018-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified 0.3 mg Intravenous
Comparator Morphine Other / unclassified 0.1 mg/kg Intravenous

Indications

No indication recorded.